SCHEMBL6606643

SCHEMBL6606643

CCCCC1(c2ccc(-c3ccccc3)cc2)CC(O)=C(SCCc2ccccc2)C(=O)O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 4/20 0.41
MMP2 P08253 2/20 0.36
MMP9 P14780 2/20 0.36
CCR6 P51684 1/20 0.33
PAX8 Q06710 1/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
CYP3A4 P08684 3/20 0.33
HSD11B1 P28845 3/20 0.33
UTS2R Q9UKP6 2/20 0.33
LDHB P07195 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
RARB P10826 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
POLB P06746 1/20 0.31
TRPV1 Q8NER1 1/20 0.31
PRKCA P17252 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6606575 0.91 LDHA (0.41) LDHAMMP2MMP9CCR6PAX8
SCHEMBL6604912 0.90 LDHA (0.45) LDHAMMP2MMP9MMP13LDHB
SCHEMBL6603852 0.89 LDHA (0.44) LDHAMMP2MMP9MMP13LDHB
SCHEMBL6606915 0.87 LDHA (0.47) LDHAUTS2RLDHB
SCHEMBL6604082 0.84 LDHA (0.47) LDHALDHBPTGDR2
SCHEMBL6607939 0.83 LDHA (0.50) LDHALDHB
SCHEMBL6604923 0.82 LDHA (0.43) LDHAMMP9LDHB
SCHEMBL6608127 0.82 LDHA (0.45) LDHALDHB
SCHEMBL6604997 0.81 LDHA (0.44) LDHALDHBPTGDR2
SCHEMBL6603220 0.81 LDHA (0.46) LDHAMMP2MMP9MMP13LDHB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729463-B1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2002-05-22 EP claimed
EP-0729463-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014011-A2 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-1142887-B1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE DAVIS & CO (US) 2004-04-07 EP disclosed
EP-0729463-B1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2002-05-22 EP disclosed
EP-1142887-A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE, DAVIS & COMPANY (US) 2001-10-10 EP disclosed
EP-0729464-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729463-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014012-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014011-A2 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed